Selected Publications

Flack KF, George MD, Kim JS, Hsu JY, Podolanczuk AJ, Hoffman E, Johnson C, McGroder CF, Smith, BM, Kreider ME, Kawut SM, Barr RG, Anderson MR, Bernstein EJ. : Antinuclear antibodies and progression of quantitative interstitial lung changes: The Multi-Ethnic Study of Atherosclerosis (MESA)-Lung Study. Respiratory Medicine March 2025.

Ramadurai D, Flack K, Wu L, Kass-Gergi S, Heath J, Kreider M, Dine CJ, Secunda K. : Coordinator-implemented algorithm for identifying spirometric progression to screen for progressive pulmonary fibrosis clinical trials. ATS Scholar March 2025.

Kim JS, Flack KF, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson MR, Hoffman EA, Podolanczuk AJ, Yun J, McDermott G, Sparks JA, Moll M, Rich S, Rotter J, Noth I, Raghu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake GM, Cho MH, Garcia CK, Barr RG, Bernstein EJ: Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities Ann Am Thorac So 2024.

Friedman Flack K, George M, Podolanczuk A, Kim J, Hoffman E, Johnson C, McGroder C, Smith B, Garcia C, Kreider M, Kawut S, Barr R.G, Anderson M, Bernstein E.: Antinuclear antibodies and progression of high attenuation areas on chest computed tomography: the Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. American Thoracic Society May 2023 Notes: Poster discussion session.

Friedman Flack K & Katzen J. : Revealing the rare: Pulmonary fibrosis from surfactant-related gene mutation. CHEST. 163(4): 744-745, Apr 2023.

Kim J, Flack K, Malik V, Manichaikul A, Sakaue S, Luo Y, Anderson M, Hoffman E, Podolanczuk A, Yun J, McDermott G, Sparks J, Moll M, Rich S, Rotter J, Noth I, Ragu G, Giles J, Winchester R, Raychaudhuri S, Hunninghake G, Cho M, Garcia C, Barr R.G, Bernstein E.: Association of rheumatoid arthritis-related antibodies, HLA-DRB1, and MUC5B (rs35705950) with high attenuation areas, forced vital capacity, and interstitial lung abnormalities. International Colloquium on Lung and Airway Fibrosis Oct 2022 Notes: Poster session.

Friedman Flack, K., Gao, G.M., Berstein, E., Johnson, C., Diamond, J., Benvenuto, L. Arcasoy, S., Greeland, J., Betancourt, L., Oyster, M., Brown, M., Kalman, L., Zaleski, D., Adler, J., Tevald, M., Balar, P., Patel, S., Medikonda, N., Kreider, M., Christie, J., Singer, J., Anderson, M.: Differences in body composition and frailty between lung transplant candidates with connective tissue disease-related interstitial lung disease and idiopathic pulmonary fibrosis. American Thoracic Society May 2022 Notes: Poster session.

Friedman Flack K, Grimm J, Haas A, Jarrar D, Szeto W, Palevsky H.: Massive hemoptysis secondary to an aortomediastinoparenchymal fistula. American Thoracic Society International Conference. Aug 2020 Notes: Virtual Poster session.

Friedman Flack K, Chu S, Ciunci C, Berman A, Kreider M, Porteous M.: The management and outcomes of patients with both interstitial lung disease and lung cancer. American Thoracic Society International Conference. Dallas, TX May 2019 Notes: Poster session.

Kolb JM*, Friedman Flack K*, Chatterjee-Murphy P, Desai J, Wallentin L, Ezekowitz M, Connolly S, Reilly P, Brueckmann M, Ilgenfritz J, Aisenberg J. *co-first authors: Locations and mucosal lesions responsible for major gastrointestinal bleeding in patients on warfarin or dabigatran. Dig Dis Sci. 63(7): 1878-1889, Jul 2018.